Aids incidence and mortality in a hospital-based cohort of HIV-1-seropositive patients receiving highly active antiretroviral therapy in São Paulo, Brazil

AIDS Patient Care and STDs

Volumn 17, Issue 9, 2003, Pages 447-452

  Casseb, Jorge ^a   Rodrigues, Rosangela ^b   Santos, Niraldo ^a   Malacarne, Eunice ^a   Ronchini, Karla O M ^a   Zihlmann, Karina F ^a   Duarte, Alberto J S ^a   Marcondes Fonseca, Luiz Augusto ^a   Rocha Veiga, Ana Paula ^a   De Almeida, Alexandre ^a   Bueno, Analice ^a   Ferez, Antonio Carlos ^a   Gonsalez, Claudio R ^a   Brigido, Luis F M ^b   Mendonça, Marcelo ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUTO ADOLFO LUTZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; DIDANOSINE; PROTEINASE INHIBITOR; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AIDS RELATED COMPLEX; ARTICLE; BRAZIL; DEATH; FEMALE; FOLLOW UP; HEALTH CARE ACCESS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; INCIDENCE; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROGNOSIS; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; T LYMPHOCYTE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BRAZIL; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; HIV-1; HUMANS; INCIDENCE; MALE; OUTPATIENT CLINICS, HOSPITAL; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SURVIVAL ANALYSIS; VIRAL LOAD;

EID: 0141706720     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/108729103322395474     Document Type: Article

References (11)

1. Piot P, Batos M, Ghys PD, Walker N, Schwartlander B. The global impact of HIV/AIDS. Nature 2001;410:968-973.
2. AIDS: Boletim Epidemiológico. Ministério da Saúde/Programa Nacional de DST/AIDS. 2001, Ano XIV, N° 02.
3. AIDS: Boletim Epidemiológico. Ministério da Saúde/Programa Nacional de DST/AIDS. 1999, Ano XII, N° 3.
4. Galvão J. Access to antiretroviral drugs in Brazil. Lancet 2002;360:1862-1865. Online document at: image.thelancet.com/extras/0lart9038web.pdf
5. Levi GC, Vitória MA. Fighting against AIDS: The Brazilian experience. AIDS 2002;16:2373-2383.
6. Fonseca LA, Reingold AL, Casseb J, Brígido LFM, Duarte AJS. AIDS incidence and survival in a hospital-based cohort of asymptomatic HIV patients in São Paulo, Brazil. Int J Epidemiol 1999;28:1156-1160.
7. Centers for Disease Control and Prevention: Revision of the surveillance case definition for acquired immunodeficiency syndrome. MMWR 1987;36(Suppl. 1S):1S-15S.
8. Hogg RS, Yip B, Chan KJ, et al. Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy. JAMA 2001;286: 2568-2577.
9. Phillips AN, Staszewski S, Weber R, et al. HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load. JAMA 2001;286:2560-2567.
10. Nijhuis M, Deeks S, Boucher C. Implications of antiretroviral resistance on viral fitness. Curr Opin Infect Dis 2001;14:23-28.
11. Sabin CA, Phillips AN. Treatment comparisons in HIV infection: The benefits and limitations of observational cohort studies. J Antimicrob Chemother 2001;47:371-375.